ArticleFrontiers in oncology2019

21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.

Wen-Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.